ATTENTION: HealthWell Foundation’s hotline will close at 3:00 p.m. on Tuesday, November 5, 2024, to allow staff to exercise their civic duty of voting, and will re-open on Wednesday, November 6, 2024, at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time. If you have a question that cannot be answered by visiting the portal, please send an email to [email protected]. We apologize for any inconvenience and look forward to serving you. The HealthWell Team
Schizophrenia - Medicare Access (Medicare patients only)
Status
OpenFund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- 5-mthf
- Abilify
- Adasuve
- Allopurinol
- Amitriptyline And Perphenazine
- Aripiprazole
- Aripiprazole Lauroxil
- Aristada
- Asenapine
- Brexpiprazole
- Calcium L-5-methyltetrahydrofolate
- Caplyta
- Cariprazine
- Chlorpromazine Hydrochloride
- Clozapine
- Clozaril
- Cobenfy
- Cyproheptadine Hydrochloride
- Depakote
- Deplin 15
- Deplin Fc
- Dexmedetomidine
- Divalproex Sodium
- Elfolate
- Fanapt
- Fluphenazine Decanoate
- Fluphenazine Hydrochloride
- Geodon
- Haldol Decanoate
- Haloperidol
- Haloperidol Decanoate
- Haloperidol Lactate
- Igalmi
- Iloperidone
- Invega
- L-methylfolate
- L-methylfolate Calcium
- Latuda
- Lithobid
- Loxapine
- Lumateperone
- Lurasidone Hydrochloride
- Lybalvi
- Memantine Hcl
- Minocycline Hcl
- Minolira
- Molindone Hcl
- Namenda
- Olanzapine
- Olanzapine And Samidorphan
- Ondansetron
- Perphenazine
- Perseris
- Pimozide
- Prochlorperazine Edisylate
- Prochlorperazine Maleate
- Rexulti
- Risperdal
- Risperidone
- Rykindo
- Saphris
- Secuado
- Seroquel
- Thioridazine Hcl
- Thiothixene
- Trifluoperazine Hcl
- Versacloz
- Vraylar
- Xanomeline And Trospium
- Ximino
- Ziprasidone Hydrochloride
- Ziprasidone Mesylate
- Zofran
- Zyloprim
- Zyprexa
Autism Spectrum Disorder (including ADD and ADHD)
- Lithium
- Lithium Carbonate
- Lithium Citrate
- Loxapine Succinate
- Paliperidone
- Quetiapine
- Quetiapine Fumarate
- Valproic Acid
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of Schizophrenia.
Grant Utilization
HealthWell estimates that patients use an average of $2,500 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Schizophrenia
Schizophrenia is a spectrum of serious neuro-psychiatric brain diseases in which people interpret reality abnormally. It may result in some combination of hallucinations, delusions and extremely disordered thinking and behavior that impairs daily life. Schizophrenia and related psychosis disorders affect at least 1 in 100 people in the United States – or about 2 million adults. People with schizophrenia typically require lifelong treatment.
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.